Recent news on Zometa

ASCO Releases Updated Guideline On The Role Of Bisphosphonates For ...  -  May 19, 2007
Medical News Today (press release),The manufacturer of Zometa previously recommended lowering the treatment dose for these patients as well. The guideline includes new recommendations for

Yearly Infusions With Zoledronic Acid Reduce Risk of Fractures in ...  -  May 10, 2007
DG News..."Compared to placebo, once-yearly infusion with Zometa for three years resulted in significant and sustained decreases in vertebral, hip and nonvertebral

New hope, concern on osteoporosis  -  May 3, 2007
Philadelphia Inquirer,Novartis Pharmaceuticals Corp. got approval six years ago to market zoledronic acid as Zometa for cancer-related bone weakening.

Doctors Study Yearly Osteoporosis Treatment  -  May 2, 2007
INDYchannel.com,The study, in which Indiana University School of Medicine physicians participated, showed that taking Zometa intravenously for 15 minutes once a year could

The Ultimate in Drug Adherence  -  May 16, 2007
HealthandAge.comZoledronic acid (Zometa®) given once-a-year effectively reduces the risk for vertebral and hip fractures in patients with osteoporosis, according to the

Once-yearly Reclast Significantly Reduced Bone Fractures in Women ...  -  May 3, 2007
PharmaLive.com (press release),The active ingredient in Reclast is zoledronic acid, which is also available under the brand name Zometa(R) (zoledronic acid) Injection for use in certain

Once-a-year treatment stops fractures  -  May 9, 2007
United Press InternationalSAN DIEGO, May 9 (UPI) -- A once-a-year treatment with zoledronic acid -- sold as Zometa -- can help women with osteoporosis avoid hip and back fractures,

Breakthrough drug may make life easier for osteoporosis sufferers  -  May 3, 2007
49abcnews.com,A study of over 7500 postmenopausal women finds that a simple yearly IV infusion of the drug Zometa, also known as Reclast, can reduce spine fractures by 70

Experimental osteoporosis drug found to curb fractures  -  May 2, 2007
Milwaukee Journal Sentinel (subscription),A different version of zoledronic acid, called Zometa, is already approved for use in cancer patients to treat a condition in which calcium leaches from the

Once-a-year medication may help with osteoporosis  -  May 2, 2007
WVEC.com (subscription),More than 7500 postmenopausal women took a yearly infusion of Zometa, a drug that's often prescribed for cancer patients, to help reduce or delay bone

Yearly anti-osteoporosis jab goes straight to the bone  -  May 8, 2007
Chemistry World,The drug is already marketed by Novartis as Zometa (zoledronic acid) for use in several other disorders, including the genetic bone-softening disorder

Jawbones susceptible to unique pressures  -  May 5, 2007
StarPhoenix,Reports of a possible link between the oral bisphosphonates (Fosamax, Actonel, Boniva) and also the intravenous ones ( Aredia, Zometa, Bonefos),

Report touts new drug to fight osteoporosis  -  May 3, 2007
Seattle Times,The drug is sold by drug maker Novartis in the US under the brand name Zometa to treat Paget's disease — a genetic disorder in which bone becomes soft and

Once-yearly drug reduces postmenopausal fractures  -  May 2, 2007
Houston Chronicle,The drug already is sold by drug maker Novartis in the United States under the brand name Zometa for the treatment of Paget's disease and the prevention of

It's Amazing, It's Incredible, It's Anonymous?  -  May 3, 2007
NewsBusters...there was no love for Novartis and no mention of the millions of dollars they spent developing the product which is marketed as Reclast and Zometa.

Once-yearly medication shown to significantly reduce bone ...  -  May 2, 2007
CNW Telbec (Communiqués de presse),Zoledronic acid, the active ingredient of Aclasta, is also available in a different formulation and dose under the brand name Zometa(*) for use in other

Networks Praise Osteoporosis Drug, Neglect To Credit Novartis  -  May 14, 2007
Seeking Alpha,It is sold under the brand names Reclast and Zometa. But neither CBS nor ABC mentioned the maker of the new treatment: Novartis Pharmaceuticals (NVS).

A new option to fight bone loss  -  May 3, 2007
Baltimore Sun,She went for her first dose of intravenous Zometa on Tuesday and said the entire doctor's visit took about an hour. Doctors hope patients such as Hemmes

Study: Drug for osteoporosis given only once a year works  -  May 3, 2007
San Jose Mercury News,The drug already is sold by Novartis in the United States under the brand name Zometa for the treatment of Paget's disease - a genetic disorder in which

Simpler treatment found to reduce postmenopausal fracture  -  May 2, 2007
Boston Globe,The drug already is sold by drug maker Novartis in the United States under the brand name Zometa for the treatment of Paget's disease -- a genetic disorder

Novartis Medicine Benefits Osteoporosis Patients, Study Finds  -  May 2, 2007
BloombergReclast, also sold as the cancer drug Zometa, is given intravenously. The process takes about 15 minutes. Patients may need to see a specialist to receive

An injection a year may keep bone loss at bay  -  May 3, 2007
ABC7Chicago.com,...of zoledronic acid, also known as Zometa or Reclast, reduced spine fractures by 70 percent and hip fractures by 41 percent over a three-year period.

New drug cuts bone fractures in women  -  May 3, 2007
The Spokesman Review,The drug already is sold by drug maker Novartis in the United States under the brand name Zometa for the treatment of Paget's disease – a genetic disorder

Once-a-year treatment for osteoporosis  -  May 2, 2007
7Online.com,The IV drug is zoledronic acid, also called zometa and reclast. A study in the New England Journal of Medicine reports on the effects of zoledronic acid in

Cancer patients forced to dig deep to pay for new generation of drugs  -  Apr 26, 2007
Globe and Mail,Zoledronic acid for injection (Zometa): A new biophosphonate that helps slow the destruction of bone. It is used to treat cancer that has spread from cancer

Cancer patients dig deep to pay for new drugs  -  26 Apr 2007
Globe and Mail,Zoledronic acid for injection (Zometa): A new biophosphonate that helps slow the destruction of bone. It is used to treat cancer that has spread from cancer

Single Annual Zometa Increases Bone Mass in Prostate Cancer  -  Mar 29, 2007
Cancerpage.com,NEW YORK MAR 29, 2007 (Reuters Health) - A single annual treatment with zoledronic acid appears to be sufficient to prevent bone loss in men rendered

Always best to build up bone naturally  -  Apr 20, 2007
London Free Press,Reports of a possible link between the oral bisphosphonates (Fosamax, Actonel, Boniva) and also the intravenous ones (Aredia, Zometa, Bonefos),

FDA OKs Drug for Paget's Disease  -  Apr 17, 2007
WebMDIts active ingredient, zoledronic acid, is also marketed by Novartis under the brand name Zometa for use in certain cancer patients.

Yow wants to return  -  Apr 18, 2007
N.C. State University Technician Online,She takes Zometa once a month. She said they aren't "hardcore like chemo." "My body has a chance to get back to more normal," Yow said.

Bisphosphonate-associated necrosis of the jaws  -  Mar 28, 2007
Woman Dentist Journal,She informed me that she had been diagnosed with multiple myeloma six years before and treated with monthly IV Zometa. Her previous dentist had referred her

EAU Session On "Management Options In Metastatic Prostate Cancer ...  -  Apr 2, 2007
Medical News Today (press release),The authors reported on 111 patients treated with androgen deprivation therapy and bisphosphonates (Zometa). Dental examinations were performed every 3

Novartis Oncology Holds First Breast Cancer Summit in the Levant  -  Apr 10, 2007
24-7PressRelease.com (press release)Also discussed at the summit two important and revolutionary medications in tackling the effects of breast cancer, Femara and Zometa.

Kidney cancer: New inroads on a tough disease  -  Apr 9, 2007
Waukegan News Sun,Doctors also use medications like Zometa given monthly to alleviate pain from bone metastases. At my office, we have access to a clinical trial to a very

Reclast(R) Receives US Approval As A Highly Effective Treatment ...  -  Apr 18, 2007
Medical News Today (press release),Reclast contains the same active ingredient found in Zometa. Patients already being treated with Zometa should not be treated with Reclast.

'An end to struggle, and closure'  -  Apr 8, 2007
Philadelphia Inquirer,...bone cancer drug (Zometa), chest surgery, and standard and gamma-knife radiation to my brain - gaining another year here, a few more months there.

WOMAN WITH BONE DISEASE SUES DRUGMAKER  -  Apr 6, 2007
Therapeutics Daily (subscription) (press release),She had been taking Zometa and Aredia for osteoporosis. The drug is commonly prescribed for cancer patients, according to the Novartis Web site.

Novartis licences lead cancer candidate from Antisoma  -  Apr 23, 2007
In-PharmaTechnologist.com,...its current arsenal of anticancer treatments: Femara (letrozole), Glivec (imatinib), Sandostatin LAR (octreotide acetate) and Zometa (zoledronic acid).

Reclast Receives US Approval As A Highly Effective Treatment For ...  -  Apr 23, 2007
Medical News Today (press release),Zoledronic acid, the active ingredient of Aclasta/Reclast, is also available under the brand name Zometa for use in other indications.

Cancer patients laud Edwards  -  Mar 28, 2007
Rocky Mountain News,Then, Dr. Anthony Elias at the Anschutz Cancer Center in Aurora started her on a new regimen of medicine: Zometa to rebuild bones; Herceptin,

Cancer patients' bone loss is treatable  -  Mar 25, 2007
St. Petersburg Times,Zoledronic acid (Zometa) is an intravenous bisphosphonate used to treat patients with breast and other solid tumors that have metastasized to the bones.

Zometa and Aredia Join Forces to Treat Bone Mets  -  Mar 18, 2007
TopCancerNews.com,A Phase III study has reported that two years after starting bisphosphonate treatment, women who took Zometa went longer without bone difficulties that

Annual Zolodex® Effective in Preventing Bone Loss from Androgen ...  -  Mar 21, 2007
Cancer Consultants (press release),Previous studies have shown that Zometa administered every 3-4 months can prevent or reverse bone loss after starting ADT (See related news).

Advances in prostate cancer  -  Mar 19, 2007
Citrus County Chronicle,Already, taxotere-based chemotherapy and bone-strengthening drugs such as Zometa help these patients considerably. At the same time, the future is brighter

Elizabeth Edwards and Her Cancer: A Controllable Disease  -  Mar 22, 2007
U.S. News & World Report,The drugs, Zometa and Aredia, are similar to drugs taken to combat osteoporosis but are more powerful and are given intravenously rather than orally.

Novartis Is a Pipeline Dream  -  Mar 14, 2007
Barron's (subscription)And five drugs -- the blood-pressure drugs Diovan and Lotrel, the cancer drugs Gleevec and Zometa, and fungus-fighting treatment Lamisil -- generated almost

Ask Dr. H | Stick with Norvasc  -  Jan 29, 2007
Philadelphia Inquirer,It's a rare condition linked to the use of bone-building drugs like Zometa, Aredia and Fosamax - particularly the intravenous forms.

GTX releases positive data for prostate cancer drug  -  Feb 23, 2007
MarketWatchExamples of bisphosphonate drugs include Merck's Fosamax, Novartis' Zometa, Roche's Boniva, and Procter & Gamble and Sanofi-Aventis' Actonel, according to

Lower Dosing Regimens Of Bisphosphonates Show Antitumor Effects In ...  -  Feb 22, 2007
Science Daily (press release)...healthcare professionals about new precautions for the company's two bisphosphonate drugs, Zometa (zoledronic acid) and Aredia (pamidronate disodium).

Morphoproteomic Expression of H-ras (p21ras) Correlates with Serum ...  -  Feb 20, 2007
Annals of Clinical & Laboratory Science (subscription),IgA classes) with therapies utilizing two aminobisphosphonates, pamidronate (Aredia) and/or zoledronate (Zometa), in 19 patients with multiple myeloma.

Novartis Strategic Healthcare Portfolio Drives Sustained Strong ...  -  18 Jan 2007
PharmaLive.com (press release),Zometa (USD 1.3 billion, +4% lc), an intravenous bisphosphonate for patients with bone cancer, was impacted by an overall slowing of the market segment in

Zometa® Prevents Bone Loss in Premenopausal Breast Cancer Patients  -  Jan 17, 2007
Cancer Consultants (press release),Researchers affiliated with the Austrian Breast and Colorectal Cancer Study Group have reported that Zometa (zoledronic acid) prevented bone loss in

ENZYME DEFICIENCY A RARE CAUSE OF EMPHYSEMA  -  Jan 3, 2007
Charlotte Sun-Herald,...made for people like you -- those who don't get results from the more commonly prescribed osteoporosis medicines: Fosamax, Actonel, Zometa and Boniva.

Zometa® Prevents Bone Loss in Premenopausal Breast Cancer Patients  -  Dec 14, 2006
Cancer Consultants (press release),In a study of premenopausal women with early-stage breast cancer treated with a combination of hormonal therapies, use of the bisphosphonate drug Zometa®

Chemo room unlikely source of gifts  -  Dec 17, 2006
Birmingham News,Every four to six weeks, I get an infusion of a nonchemo drug called Zometa to strengthen bones damaged by cancer. I first had chemotherapy three years ago

Amgen says drug slows bone loss in cancer patients  -  Dec 15, 2006
Therapeutics Daily (subscription) (press release),Bisphosphonates, including Novartis AG's Zometa and Aredia, help in about one third of cases, said Dr. Allan Lipton, professor

Two-Year Z-FAST Trial Shows Zoledronic Acid Prevents Bone Loss in ...  -  Dec 18, 2006
DG NewsTwo-year interim results from the Zometa-Femara Adjuvant Synergy Trial (Z-FAST) indicate that patients who were assigned to intravenous treatment with

Zoledronic Acid Plus Letrozole Concurrent Treatment Prevents Bone ...  -  Dec 18, 2006
DG NewsThe women were divided into 2 groups; 833 women were administered the intravenous bisphosphonate zoledronic acid (Zometa) 4 mg every 6 months concurrently

Amgen says drug slows bone loss in cancer patients  -  Dec 15, 2006
ReutersVX: Quote, Profile , Research) Zometa and Aredia, which help in about a third of cases, said Dr. Allan Lipton, professor of medicine/oncology at Penn State

Better Outcomes With Zoledronic Acid Thank Pamidronate in Multiple ...  -  Dec 13, 2006
DG News...zoledronic acid (Zometa) than with pamidronate, researchers said here at the American Society of Hematology (ASH) 48 th Annual Meeting and Exhibition.

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...  -  Nov 29, 2006
Medical News Today (press release),Zometa (zoledronic acid) is on track for EU submission in the 2007 first quarter for the treatment of bone loss associated with aromatase inhibitors,

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 5, 2006
PharmaLive.com (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa(R), Femara(R) and Gleevec(R).

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 4, 2006
Business Wire (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa®, Femara® and Gleevec®.

Second-line Treatment with Zometa® Improves Symptoms in Patients ...  Oct 26, 2006
...a worsening of bone metastases during bisphosphonate therapy with Aredia® (pamidronate) or Bonefos® (clodronate), switching to Zometa® (zoledronic acid) can ... -Cancer Consultants (press release), Zometa® Reduces Bone Loss in Prostate Cancer  Oct 17, 2006
According to an article recently published in the Journal of Urology, Zometa® (zoledronic acid) appears to reduce bone loss caused by hormone therapy among ... -Cancer Consultants (press release), Patients with Breast Cancer Bone Metastasis Failing Bonefos® or ...  Oct 31, 2006
Researchers from Canada have reported Zometa® (zoledronic acid) can improve pain control in patients with breast cancer who have worsening of bone metastases ... -Cancer Consultants (press release), Beloved doctor faces greatest challenge  Nov 1, 2006
...“I won’t be having any more of them, but will receive infusions of Zometa to infuse calcium in my bones once per month,â€? he said. ... -Petaluma Argus-Courier, Jaw Infections/Osteoporosis Drugs  Nov 3, 2006
Novartis, the maker of Aredia® and Zometa®, has issued an advisory to alert health professionals about the risks of osteonecrosis of the jaw. ... -WSOCtv.com, Foro de Shell Security - Seguridad informática  Oct 27, 2006
...homa, or lymphoblastic lymphoma. CNS prophylaxis for bone m zometa rrow involvement is controversial. Treatment of acute lymphobla ... -Shell Security, Novartis Sees Record Results  Oct 19, 2006
Lotrel gained 32% to $355 million. Sales of the cancer-pain drug Zometa added 5% to $317 million. Big-percentage gainers included the ... -TheStreet.com Handling treatment  Oct 9, 2006
It began with intense chemotherapy of cytoxan and adriamycin every 28 days for six months and also with zometa, a bone treatment. ... -Jackson Sun, Jawbone Death a Risk to Consumers of Certain Osteoporosis Drugs  Oct 11, 2006
...of osteoporosis, and the class includes the oral medications Fosamax, Actonel, and Boniva and the intravenous drugs Aredia, Bonefos, Didronel, and Zometa. ... -Newsinferno.com, Pennsylvania Dental Association: Popular Drugs Prescribed for ...  Oct 11, 2006
Boniva®, taken orally. Other drugs include Aredia®, Bonefos®, Didronel® or Zometa®, administered intravenously. Over a thousand ... -Yahoo! News (press release) Novartis Delivers Dynamic Sales and Earnings Growth in the First ...  Oct 18, 2006
Zometa (USD 944 million, +4% lc), an intravenous bisphosphonate for patients with bone metastases, has been impacted by an overall slowing of the ... -Market Wire (press release) Area Roundup: Bruins escape Saints, face Warriors today  Oct 23, 2006
...bounced into the goal. Carlos Zometa's goal staked Southern Wayne to a 4-3 lead at the outset of the second half. After sharing the ... -Wilson Daily Times (subscription), Pennsylvania Dental Association: Popular Drugs Prescribed for ...  Oct 11, 2006
R), taken orally. Other drugs include Aredia(R), Bonefos(R), Didronel(R) or Zometa(R), administered intravenously. Over a thousand ... -Earthtimes.org Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 5, 2006
PharmaLive.com (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa(R), Femara(R) and Gleevec(R).

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...  -  Nov 29, 2006
Medical News Today (press release),Zometa (zoledronic acid) is on track for EU submission in the 2007 first quarter for the treatment of bone loss associated with aromatase inhibitors,

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 4, 2006
Business Wire (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa®, Femara® and Gleevec®.



EBCC: Zometa with Femara Sooner Better Than Later in Keeping Bone  Mar 23, 2006
NICE, France, March 23 - Upfront treatment with Zometa (zoledronic acid) was significantly better than delayed Zometa at preserving bone mineral density in ... - MedPage Today

New Data Support Bondronat's Superior Renal Safety Profile Against ...  Mar 24, 2006
Although Bondronat is not currently licensed for use in multiple myeloma, the audit results add to evidence from previous studies which indicate that Bondronat ... - DG News

New Data Show Zometa Increased Bone Mineral Density in Breast ...  Mar 22, 2006
EAST HANOVER, NJ, March 22, 2006 - Zometa® (zoledronic acid) Injection infused twice per year significantly increased bone mineral density (BMD) in ... - PharmaLive.com

Enrollment Complete in First Large-scale Trial to Evaluate if ...  Mar 22, 2006
...today that enrollment is complete eight months early in the first large-scale trial to determine the impact of adjuvant treatment with Zometa® (zoledronic acid ... - PharmaLive.com

Early Use of Zoledronic Acid Prevents Letrozole-Related Bone Loss  Mar 24, 2006
March 24, 2006 (Nice, France) — Women who receive zoledronic acid (Zometa) at the initiation of breast cancer treatment with letrozole (Femara) have less ... - Medscape (subscription)

Oral Ibandronate and IV May Be Equally Efficacious in Treating ...  Mar 27, 2006
...with metastatic bone disease due to breast cancer may respond equally well to oral ibandronate (Boniva) as they do to IV zoledronic acid (Zometa), according to ... - DG News

ZO-FAST Trial Shows Early Use of Zoledronic Acid Prevents Bone ...  Mar 22, 2006
NICE, FRANCE -- March 22, 2006 -- Women with estrogen receptor-positive breast cancer have less bone loss if they start zoledronic acid (Zometa) therapy early ... - DG News

Examine How Bisphosphonates is Used in the Treatment of Bone ...  Mar 20, 2006
...-- Intravenous (IV) treatment with bisphosphonates such as pamidronate (Novartis's Aredia) and zoledronic acid (Novartis's Zometa), in conjunction with ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional